202 related articles for article (PubMed ID: 23300340)
1. Cycles of ubiquitination and deubiquitination critically regulate growth factor-mediated activation of Akt signaling.
Yang WL; Jin G; Li CF; Jeong YS; Moten A; Xu D; Feng Z; Chen W; Cai Z; Darnay B; Gu W; Lin HK
Sci Signal; 2013 Jan; 6(257):ra3. PubMed ID: 23300340
[TBL] [Abstract][Full Text] [Related]
2. The Akt DUBbed InAktive.
Lin K
Sci Signal; 2013 Jan; 6(257):pe1. PubMed ID: 23300338
[TBL] [Abstract][Full Text] [Related]
3. CYLD negatively regulates transforming growth factor-β-signalling via deubiquitinating Akt.
Lim JH; Jono H; Komatsu K; Woo CH; Lee J; Miyata M; Matsuno T; Xu X; Huang Y; Zhang W; Park SH; Kim YI; Choi YD; Shen H; Heo KS; Xu H; Bourne P; Koga T; Xu H; Yan C; Wang B; Chen LF; Feng XH; Li JD
Nat Commun; 2012 Apr; 3():771. PubMed ID: 22491319
[TBL] [Abstract][Full Text] [Related]
4. LUBAC-Recruited CYLD and A20 Regulate Gene Activation and Cell Death by Exerting Opposing Effects on Linear Ubiquitin in Signaling Complexes.
Draber P; Kupka S; Reichert M; Draberova H; Lafont E; de Miguel D; Spilgies L; Surinova S; Taraborrelli L; Hartwig T; Rieser E; Martino L; Rittinger K; Walczak H
Cell Rep; 2015 Dec; 13(10):2258-72. PubMed ID: 26670046
[TBL] [Abstract][Full Text] [Related]
5. The LEF1/CYLD axis and cIAPs regulate RIP1 deubiquitination and trigger apoptosis in selenite-treated colorectal cancer cells.
Wu P; Shi KJ; An JJ; Ci YL; Li F; Hui KY; Yang Y; Xu CM
Cell Death Dis; 2014 Feb; 5(2):e1085. PubMed ID: 24577083
[TBL] [Abstract][Full Text] [Related]
6. SCFβ-TRCP regulates osteoclastogenesis via promoting CYLD ubiquitination.
Wu X; Fukushima H; North BJ; Nagaoka Y; Nagashima K; Deng F; Okabe K; Inuzuka H; Wei W
Oncotarget; 2014 Jun; 5(12):4211-21. PubMed ID: 24961988
[TBL] [Abstract][Full Text] [Related]
7. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
8. Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.
Tauriello DV; Haegebarth A; Kuper I; Edelmann MJ; Henraat M; Canninga-van Dijk MR; Kessler BM; Clevers H; Maurice MM
Mol Cell; 2010 Mar; 37(5):607-19. PubMed ID: 20227366
[TBL] [Abstract][Full Text] [Related]
9. CYLD inhibits tumorigenesis and metastasis by blocking JNK/AP1 signaling at multiple levels.
Miliani de Marval P; Lutfeali S; Jin JY; Leshin B; Selim MA; Zhang JY
Cancer Prev Res (Phila); 2011 Jun; 4(6):851-9. PubMed ID: 21478324
[TBL] [Abstract][Full Text] [Related]
10. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD.
Zhang M; Wu X; Lee AJ; Jin W; Chang M; Wright A; Imaizumi T; Sun SC
J Biol Chem; 2008 Jul; 283(27):18621-6. PubMed ID: 18467330
[TBL] [Abstract][Full Text] [Related]
11. CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis.
Moquin DM; McQuade T; Chan FK
PLoS One; 2013; 8(10):e76841. PubMed ID: 24098568
[TBL] [Abstract][Full Text] [Related]
12. Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination.
Qiu C; Liu K; Zhang S; Gao S; Chen W; Li D; Huang Y
Drug Des Devel Ther; 2020; 14():993-1001. PubMed ID: 32184568
[TBL] [Abstract][Full Text] [Related]
13. Role of growth arrest and DNA damage-inducible α in Akt phosphorylation and ubiquitination after mechanical stress-induced vascular injury.
Mitra S; Sammani S; Wang T; Boone DL; Meyer NJ; Dudek SM; Moreno-Vinasco L; Garcia JG; Jacobson JR
Am J Respir Crit Care Med; 2011 Nov; 184(9):1030-40. PubMed ID: 21816939
[TBL] [Abstract][Full Text] [Related]
14. The E3 ligase TRAF6 regulates Akt ubiquitination and activation.
Yang WL; Wang J; Chan CH; Lee SW; Campos AD; Lamothe B; Hur L; Grabiner BC; Lin X; Darnay BG; Lin HK
Science; 2009 Aug; 325(5944):1134-8. PubMed ID: 19713527
[TBL] [Abstract][Full Text] [Related]
15. CYLD destabilizes NoxO1 protein by promoting ubiquitination and regulates prostate cancer progression.
Haq S; Sarodaya N; Karapurkar JK; Suresh B; Jo JK; Singh V; Bae YS; Kim KS; Ramakrishna S
Cancer Lett; 2022 Jan; 525():146-157. PubMed ID: 34742871
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation.
Reiley W; Zhang M; Wu X; Granger E; Sun SC
Mol Cell Biol; 2005 May; 25(10):3886-95. PubMed ID: 15870263
[TBL] [Abstract][Full Text] [Related]
17. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling.
Blake PW; Toro JR
Hum Mutat; 2009 Jul; 30(7):1025-36. PubMed ID: 19462465
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitinating activity of CYLD is impaired by SUMOylation in neuroblastoma cells.
Kobayashi T; Masoumi KC; Massoumi R
Oncogene; 2015 Apr; 34(17):2251-60. PubMed ID: 24909169
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-dependent regulation of phospho-AKT dynamics by the ubiquitin E3 ligase, NEDD4-1, in the insulin-like growth factor-1 response.
Fan CD; Lum MA; Xu C; Black JD; Wang X
J Biol Chem; 2013 Jan; 288(3):1674-84. PubMed ID: 23195959
[TBL] [Abstract][Full Text] [Related]
20. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer.
Iliopoulos D; Jaeger SA; Hirsch HA; Bulyk ML; Struhl K
Mol Cell; 2010 Aug; 39(4):493-506. PubMed ID: 20797623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
